Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Aura Biosciences, Inc. (AURA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Aura Biosciences, Inc. (AURA), most recent 12 months reported: net loss $131.01M, free cash flow -$103.35M. Latest balance sheet on file: liquid cash $323.84M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Allogene Therapeutics, Inc. · Adaptin Bio, Inc. · ARMATA PHARMACEUTICALS, INC. · Artiva Biotherapeutics, Inc. · ANAVEX LIFE SCIENCES CORP. · BIOATLA, INC. · BioCardia, Inc. · BRAINSTORM CELL THERAPEUTICS INC.

Stock screener

Watchlist